Announcement • Jan 23
Rocket Doctor AI Inc. announced that it has received CAD 5.2 million in funding On January 22, 2026,Rocket Doctor AI Inc. closed the transaction. In connection with the closing of the transaction, the company paid to certain finders cash commission of CAD 198,800 and issued 284,000 non-transferrable warrants of the Company exercisable at any time until January 22, 2027 to acquire one Common Share at an exercise price of CAD 0.85, subject to adjustment in certain events. The securities issued in the Offering are not subject to a hold period in accordance with applicable Canadian securities laws. Announcement • Dec 09
Rocket Doctor AI, Health Cities and CAN Health Network Partner to Advance AI-Powered Clinical Decision Support in Alberta Rocket Doctor AI Inc. announced a new partnership with the CAN Health Network to test its AI-powered Clinical Decision Support System (CDSS) in collaboration with Health Cities. The project will launch at up to four primary care sites in Alberta to help physicians deliver faster, evidence-based, and more efficient care. The program was developed in accordance with Health Cities' need for an integrated, AI-powered solution capable of analyzing diverse data sources, automating routine tasks, and delivering real-time clinical recommendations. The project, running from November 2025 to March 2026, involves approximately 20 clinicians and aims to set the foundation for a potential full provincial rollout in 2026. As a CAN Health Network Primary Care Edge, Health Cities creates an environment where innovative solutions can be co-developed, validated, and adopted to address real-world health challenges. The initiative rolls out in three phases, beginning with AI-powered patient intake through a website-embedded chatbot, followed by real-time clinician support during visits, and ultimately integration with electronic medical records (EMRs). Rocket Doctor AI's Global Library of Medicine (GLM) is a clinically-validated decision engine developed with input from hundreds of physicians to assist providers with triage, differential diagnosis, and evidence-based care planning. This project comes at a critical time for Alberta's healthcare system, where staffing shortages, limited access to primary care, and increasing patient loads continue to strain clinics across the province. Recent data shows that one in five Albertans lacks a family physician, with many communities facing long wait times for basic care. This project aims to directly address these challenges by supporting clinicians with intelligent, AI-driven tools that improve efficiency and patient access. Key anticipated outcomes include a 25-40% reduction in physician intake time, as well as improved patient satisfaction through faster and clearer communication. The CDSS is also expected to significantly reduce physicians' administrative workload, including less time on charting, documentation, and billing. Rocket Doctor AI's platform will be hosted in secure, Canadian-based data centres, aligned with HIPAA, PIPEDA, and Alberta's Health Information Act (HIA). The modular system architecture ensures future growth, with the capability to scale across Alberta's 4,400 providers and beyond. This project is made possible through funding and support from the CAN Health Network, a federally funded initiative designed to help Canadian companies scale innovative healthcare solutions domestically. The partnership underscores Rocket Doctor AI's commitment to advancing equitable access to care, supporting overburdened clinicians, and modernizing healthcare delivery through responsible AI innovation. A Commercialization Project Agreement was entered into by the parties on 12th November 2025. The Agreement details the intent of the parties to collaborate in jointly delivering a Commercialization Project. Either party may propose amendments or terminate this Agreement upon written notice. Announcement • Dec 06
Rocket Doctor AI Inc. Announces Change of Chief Financial Officer, Effective December 8, 2025 Rocket Doctor AI Inc. announced that Christopher Cherry shall assume the role of Interim Chief Financial Officer, to replace David Worner, effective December 8, 2025. Mr. Cherry is currently the Company’s Chair of the Audit Committee. 
